Here's why the Challenger (ASX:CGF) share price is up 80% in 6 months

The Challenger (ASX:CGF) share price has had a remarkable recovery, rising 80% over the past 6 months. Here's why this might be happening.

| More on:
Excited elderly woman on a swing.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

For many years, the Challenger Ltd (ASX: CGF) share price was one that many an ASX investor probably wished they could forget. Since peaking at above $14 per share back in late 2017, Challenger shares have been in freefall.

This is a company that bottomed out at $2.82 per share in just the past 12 months. That represents a loss of 80% over three years or so.

But the Challenger share price has staged a remarkable recovery in recent months. Challenger shares were trading at $3.63 back in mid-September last year. Today, those same shares are going for $6.55 at the time of writing. That's a recovery of ~80% in just six months, not a bad return.

So what has breathed new life into this annuities company?

Well, to answer that question, we just need to look at how Challenger makes its crust in the first place.

So (as I just mentioned), Challenger provides annuities and other investment products like funds management. But annuities make up the lion's share of its business. An annuity is a pension of sorts. You provide Challenger with a lump sum of capital, and in return, you receive a fixed percentage of that capital every year as a payment.

What makes annuities unique is the certainty they offer. Most investments don't offer a guaranteed income, as we saw last year when many traditionally solid ASX dividend-paying shares reduced or axed their dividend payments. Likewise, a house or a property can provide rent, but tenants can always move out and pull the plug on your cash flow.

Annuities take that uncertainty away – in exchange for a lower yield than what you can expect from many shares and the like of course. There's no free lunch.

A challenging time for Challenger shares

But Challenger has a difficult balancing act to pull off in order for it to make money. It has to invest its clients' funds in investments itself in order to create a spread it can take profits from. And since it is required to pay a guaranteed income for its annuities, it has to make sure it doesn't lose too much money.

Unfortunately for Challenger, the best risk-free assets – government bonds – have not had a good few years. The Reserve Bank of Australia (RBA) has been slashing interest rates progressively over the past few years (and aggressively last year). As such, government bond yields and cash interest rates have also been cratering.

Fortunately for Challenger though, the past few months have seen this situation reverse, and government bond rates rise substantially.

In November last year, 10-year Australian government bonds were yielding just 0.88% per annum. Today, those same bonds are instead offering 1.65%. At the same time, the S&P/ASX 200 Index (ASX: JXO) has been rising in tandem. As have ASX 200 dividends.

This might just be why the fortunes of the Challenger share price have been rising as well.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Challenger Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »